Molecule
Apraclonidine; LC-ESI-QFT; MS2; CE: 15%; R=15000; [M+H]+
Apraclonidine; LC-ESI-QFT; MS2; CE: 20%; R=15000; [M+H]+
Apraclonidine; LC-ESI-QFT; MS2; CE: 25%; R=15000; [M+H]+
Apraclonidine; LC-ESI-QFT; MS2; CE: 30%; R=15000; [M+H]+
Apraclonidine; LC-ESI-QFT; MS2; CE: 40%; R=15000; [M+H]+
Apraclonidine; LC-ESI-QFT; MS2; CE: 50%; R=15000; [M+H]+
2,6-dichloro-1-N-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine
Chemical Information
6 Related Dataset(s)
⌄
Metadata Information
| Field | Value |
|---|---|
| NFDI4Chem Molecule ID | nfdi4chem-mol76311 |
| Source | |
| Alternate Name |
| Field | Value |
|---|---|
| No additional information available for this Dataset. | |
| Data-Source Molecule ID | Data-Source |
|---|---|
| C07668 | KEGG Ligand |
| 2788 | ChEBI |
| DB00964 | DrugBank |
| CHEMBL647 | ChEMBL |
| APRACLONIDINE | DailyMed |
| APRACLONIDINE HYDROCHLORIDE | rxnorm |
| IOPIDINE | rxnorm |
| APRACLONIDINE | rxnorm |
| IOPIDINE | clinicaltrials |
| APRACLONIDINE | clinicaltrials |
| 81926 | BindingDB |
| DTXSID1048415 | EPA CompTox Dashboard |
| 229 | DrugCentral |
| ZINC000000020231 | ZINC |
| 7117 | Guide to Pharmacology |
| J247.956G | Nikkaji |
| 50021812 | BindingDB |
| APRACLONIDINE HYDROCHLORIDE | clinicaltrials |
| PA164748866 | PharmGKB |
| apraclonidine | DailyMed |
| HMDB0015099 | Human Metabolome Database |
| 2216 | PubChem |
| PD009614 | ProbesDrugs |
| 843CEN85DI | FDA SRS |
| 16363243 | PubChem: Thomson Pharma |
| SCHEMBL34127 | SureChEMBL |
| 14749680 | PubChem: Thomson Pharma |
| 66711-21-5 | ACToR |
| The data in this table is sourced from UniChem at EBI. | |